Table 1.

Patient characteristics.

	HIF1α inhibitors	No HIF1α inhibitors	P-value
No of patients	18	66
Average age	70 (54–84)	63.9 (44–81)	0.009
Median Gleason score	7.5 (6–9)	8 (6–10)	0.747
Median PSA at start of androgen deprivation	97 (0–5705)	407 (0–4780)	0.08
Percentage D'Amico high-risk disease (%)	46	59	0.50
Median follow-up (years)	3.2 (0.34–9.5)	2.3 (1.0–8.5)	0.099

HIF, hypoxia-inducible factor; PSA, prostate-specific antigen. The baseline characteristics of the patients with and without HIF1α inhibitor treatment are shown. Differences between the two groups were analyzed using Wilcoxon and Mann–Whitney U tests and P-values were calculated. The range is demonstrated within brackets.